Results 141 to 150 of about 29,410 (210)

Treating myocardial infarction combined with depression via regulating M1/TNF-α/TNFR1/NF-κB. [PDF]

Biochem Biophys Rep
Zhang L, Liu M, Chen H.
europepmc   +1 more source

H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2⁺ T_reg recruitment. [PDF]

Exp Mol Med
Ye L, Xiang X, Wang Z, Zhang S, Xue Q, Wei X, Liu Y, Wang H, Ai J, Yang B, Chen L, Niu Y, Peng W, Zhou Q.   +13 more
europepmc   +1 more source

Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17 [PDF]

, 2016
Aghaeepour, N, Blobel, CP, Brooke, MA, Evers, A, Haeussinger, D, Kelsell, DP, Lang, KS, Lang, PA, Mak, TW, Maney, SK, Maretzky, T, Mcllwain, DR, Muenk, C, Nolan, GP, Ohishi, K, Pandyra, AA, Polz, R, Scheller, J, Sundaram, B, Vasudevan, AAJ, Wolff, D   +20 more
core   +1 more source

A bispecific antibody targeting PD-L1/TNFR2 increases tumor targeting and enhances antitumor efficacy in colorectal cancer. [PDF]

J Immunother Cancer
Kang X, Qian P, Han Y, Wu M, Li Y, Xu C, Wei J.   +6 more
europepmc   +1 more source

The Role of TNF-α in Ischemic Stroke. [PDF]

Int J Mol Sci
Kołodziejska R, Pawluk H, Tafelska-Kaczmarek A, Pawluk M, Koper K, Godlewski A, Kuk J, Sergot K, Kurhaluk N, Woźniak A.   +9 more
europepmc   +1 more source

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19. [PDF]

Mol Biomed
Qiao Y, Han Y, Zhao L, Gao W, Hu H, Su C, Zheng A, Sun J, Tian M, Wu Y, Bai L, Lei Y, Wu J, Zhang W, Han P, Li X, Dong C, Wang H, Liu Z, Han P.   +19 more
europepmc   +1 more source

TNF Production or TNFR2 Expression Characterize Distinct States of Regulatory T Cells that Cooperate in Treg Expansion in Cancer and Chronic Inflammation. [PDF]

Eur J Immunol
Tucci G, Pacella I, Pinzon Grimaldos A, Rossi A, Cammarata I, Zagaglioni M, Peruzzi G, Tirelli V, Sanchez M, Pietropaolo G, Sozio F, Del Prete A, Licursi V, Barnaba V, Piconese S.   +14 more
europepmc   +1 more source

Antigen-directed single domain antibody-based TNFR1 agonists elicit preferential killing of HER2-overexpressing cancer cells. [PDF]

iScience
Unmuth L, Lipinski B, Hoerr A, Harwardt J, Guarnera E, Szczepek M, Becker S, Menrad A, Scheerer P, Evers A, Krah S, Elter D, Pekar L, Zielonka S.   +13 more
europepmc   +1 more source

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation. [PDF]

Front Immunol
Kang X, Yang X, Wu H, Tong X, Wang S.
europepmc   +1 more source

TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases. [PDF]

Int J Mol Sci
Faustman DL, Davis M, Kuhtreiber WM.
europepmc   +1 more source